[SCHEDULE 13G/A] DarioHealth Corp. SEC Filing
DarioHealth Corp. reporting persons Nantahala Capital Management, LLC and principals Wilmot B. Harkey and Daniel Mack disclose beneficial ownership of 4,690,019 shares, representing 9.99% of the outstanding common stock as of June 30, 2025. The disclosed position includes 2,997,716 shares that may be acquired within 60 days through the exercise of warrants, and all voting and dispositive power is reported as shared rather than sole. Nantahala identifies two advised funds with rights to receive proceeds or dividends from more than 5% of the shares reported.
DarioHealth Corp. i soggetti segnalanti Nantahala Capital Management, LLC e i dirigenti Wilmot B. Harkey e Daniel Mack comunicano la propriet脿 effettiva di 4.690.019 azioni, pari al 9,99% del capitale sociale ordinario in circolazione al 30 giugno 2025. La posizione dichiarata comprende 2.997.716 azioni che possono essere acquisiste entro 60 giorni mediante l'esercizio di warrant, e tutti i diritti di voto e dispositivi sono indicati come condivisi anzich茅 esclusivi. Nantahala segnala inoltre due fondi consulenti con diritto a ricevere proventi o dividendi su oltre il 5% delle azioni segnalate.
DarioHealth Corp. los informantes Nantahala Capital Management, LLC y los principales Wilmot B. Harkey y Daniel Mack revelan la propiedad beneficiaria de 4.690.019 acciones, que representan el 9,99% del capital social ordinario en circulaci贸n al 30 de junio de 2025. La posici贸n declarada incluye 2.997.716 acciones que pueden adquirirse dentro de 60 d铆as mediante el ejercicio de warrants, y todos los poderes de voto y disposici贸n se informan como compartidos en lugar de exclusivos. Nantahala identifica adem谩s dos fondos asesorados con derecho a recibir ingresos o dividendos sobre m谩s del 5% de las acciones reportadas.
DarioHealth Corp.鞚� 氤搓碃鞛� Nantahala Capital Management, LLC鞕� 欤检殧鞚鸽 Wilmot B. Harkey 氚� Daniel Mack電� 2025雲� 6鞗� 30鞚�9.99%鞐� 頃措嫻頃橂姅 4,690,019欤检棎 雽�頃� 鞁れ鞝� 靻岇湢毳� 瓿奠嫓頃╇媹雼�. 瓿奠嫓霅� 氤挫湢鞐愲姅 鞗岆煱韸� 頄夓偓搿� 60鞚� 鞚措偞鞐� 旆摑頃� 靾� 鞛堧姅 2,997,716欤缄皜 韽暔霅橂┌, 氇摖 鞚橁舶甓� 氚� 觳橂秳 甓岉暅鞚� 雼弲鞚� 鞎勲媽 瓿惦彊鞙茧 氤搓碃霅╇媹雼�. Nantahala電� 霕愴暅 氤搓碃霅� 欤检嫕鞚� 5% 齑堦臣鞐� 雽�頃� 靾橃澋鞚措倶 氚半嫻鞚� 氚涭潉 甓岆Μ臧� 鞛堧姅 霊� 臧滌潣 鞛愲 韼�霌滊ゼ 鞁濍硠頃╇媹雼�.
DarioHealth Corp. les personnes d茅clarante Nantahala Capital Management, LLC et les dirigeants Wilmot B. Harkey et Daniel Mack d茅clarent une d茅tention b茅n茅ficiaire de 4 690 019 actions, repr茅sentant 9,99% des actions ordinaires en circulation au 30 juin 2025. La position divulgu茅e inclut 2 997 716 actions pouvant 锚tre acquises dans les 60 jours par l'exercice de warrants, et tous les pouvoirs de vote et de disposition sont indiqu茅s comme 辫补谤迟补驳茅蝉 plut么t que exclusifs. Nantahala identifie 茅galement deux fonds conseill茅s ayant le droit de recevoir des produits ou dividendes sur plus de 5% des actions d茅clar茅es.
DarioHealth Corp. meldende Personen Nantahala Capital Management, LLC und die Verantwortlichen Wilmot B. Harkey und Daniel Mack geben den wirtschaftlichen Besitz von 4.690.019 Aktien bekannt, was 9,99% des zum 30. Juni 2025 ausstehenden Stammkapitals entspricht. Die gemeldete Position umfasst 2.997.716 Aktien, die innerhalb von 60 Tagen durch Aus眉bung von Warrants erworben werden k枚nnen, und s盲mtliche Stimm- und Verf眉gungsrechte werden als geteilt statt als allein angegeben. Nantahala benennt zudem zwei beratenen Fonds mit dem Recht, Ertr盲ge oder Dividenden aus mehr als 5% der gemeldeten Aktien zu erhalten.
- Significant disclosed stake: 4,690,019 shares reported, demonstrating substantial economic interest in DRIO
- Transparency on exercisable warrants: Filing explicitly states 2,997,716 shares may be acquired within 60 days
- Identification of economic beneficiaries: Specific funds advised by Nantahala are named as having rights to proceeds or dividends
- Position just below 10%: Reported ownership is 9.99%, which avoids certain regulatory thresholds that apply at or above 10%
- All power is shared: No sole voting or dispositive power reported, limiting clarity on who would act unilaterally
Insights
TL;DR: Nantahala and two principals report a near-10% shared stake, including exercisable warrants that could increase effective ownership.
The Schedule 13G/A shows a meaningful but sub-10% position in DRIO of 4,690,019 shares (9.99%), including 2,997,716 warrant-based shares exercisable within 60 days. Shared voting and dispositive power indicates control is exercised collectively through the adviser and named principals. The position is large enough to be material to investors but remains below 10%, avoiding certain reporting triggers. Identification of specific advised funds clarifies who economically benefits from the holdings.
TL;DR: Reporting persons disclose collective influence but not sole control; governance impact depends on coordination among stakeholders.
The filing classifies Nantahala as an investment adviser and Messrs. Harkey and Mack as control persons regarding the shares held by funds under Nantahala's control. All reported voting and dispositive power is shared, which suggests decisions are made through the adviser/fund structure rather than by a single individual. The disclosure that certain advised funds have the right to receive proceeds clarifies economic beneficiaries, which is important for assessing potential governance actions.
DarioHealth Corp. i soggetti segnalanti Nantahala Capital Management, LLC e i dirigenti Wilmot B. Harkey e Daniel Mack comunicano la propriet脿 effettiva di 4.690.019 azioni, pari al 9,99% del capitale sociale ordinario in circolazione al 30 giugno 2025. La posizione dichiarata comprende 2.997.716 azioni che possono essere acquisiste entro 60 giorni mediante l'esercizio di warrant, e tutti i diritti di voto e dispositivi sono indicati come condivisi anzich茅 esclusivi. Nantahala segnala inoltre due fondi consulenti con diritto a ricevere proventi o dividendi su oltre il 5% delle azioni segnalate.
DarioHealth Corp. los informantes Nantahala Capital Management, LLC y los principales Wilmot B. Harkey y Daniel Mack revelan la propiedad beneficiaria de 4.690.019 acciones, que representan el 9,99% del capital social ordinario en circulaci贸n al 30 de junio de 2025. La posici贸n declarada incluye 2.997.716 acciones que pueden adquirirse dentro de 60 d铆as mediante el ejercicio de warrants, y todos los poderes de voto y disposici贸n se informan como compartidos en lugar de exclusivos. Nantahala identifica adem谩s dos fondos asesorados con derecho a recibir ingresos o dividendos sobre m谩s del 5% de las acciones reportadas.
DarioHealth Corp.鞚� 氤搓碃鞛� Nantahala Capital Management, LLC鞕� 欤检殧鞚鸽 Wilmot B. Harkey 氚� Daniel Mack電� 2025雲� 6鞗� 30鞚�9.99%鞐� 頃措嫻頃橂姅 4,690,019欤检棎 雽�頃� 鞁れ鞝� 靻岇湢毳� 瓿奠嫓頃╇媹雼�. 瓿奠嫓霅� 氤挫湢鞐愲姅 鞗岆煱韸� 頄夓偓搿� 60鞚� 鞚措偞鞐� 旆摑頃� 靾� 鞛堧姅 2,997,716欤缄皜 韽暔霅橂┌, 氇摖 鞚橁舶甓� 氚� 觳橂秳 甓岉暅鞚� 雼弲鞚� 鞎勲媽 瓿惦彊鞙茧 氤搓碃霅╇媹雼�. Nantahala電� 霕愴暅 氤搓碃霅� 欤检嫕鞚� 5% 齑堦臣鞐� 雽�頃� 靾橃澋鞚措倶 氚半嫻鞚� 氚涭潉 甓岆Μ臧� 鞛堧姅 霊� 臧滌潣 鞛愲 韼�霌滊ゼ 鞁濍硠頃╇媹雼�.
DarioHealth Corp. les personnes d茅clarante Nantahala Capital Management, LLC et les dirigeants Wilmot B. Harkey et Daniel Mack d茅clarent une d茅tention b茅n茅ficiaire de 4 690 019 actions, repr茅sentant 9,99% des actions ordinaires en circulation au 30 juin 2025. La position divulgu茅e inclut 2 997 716 actions pouvant 锚tre acquises dans les 60 jours par l'exercice de warrants, et tous les pouvoirs de vote et de disposition sont indiqu茅s comme 辫补谤迟补驳茅蝉 plut么t que exclusifs. Nantahala identifie 茅galement deux fonds conseill茅s ayant le droit de recevoir des produits ou dividendes sur plus de 5% des actions d茅clar茅es.
DarioHealth Corp. meldende Personen Nantahala Capital Management, LLC und die Verantwortlichen Wilmot B. Harkey und Daniel Mack geben den wirtschaftlichen Besitz von 4.690.019 Aktien bekannt, was 9,99% des zum 30. Juni 2025 ausstehenden Stammkapitals entspricht. Die gemeldete Position umfasst 2.997.716 Aktien, die innerhalb von 60 Tagen durch Aus眉bung von Warrants erworben werden k枚nnen, und s盲mtliche Stimm- und Verf眉gungsrechte werden als geteilt statt als allein angegeben. Nantahala benennt zudem zwei beratenen Fonds mit dem Recht, Ertr盲ge oder Dividenden aus mehr als 5% der gemeldeten Aktien zu erhalten.
FAQ
How many DarioHealth (DRIO) shares does Nantahala report owning?
What percentage of DRIO does the reported position represent?
Does the filing include shares that can be acquired soon?
Do the reporting persons have sole voting or dispositive power over the shares?
Which funds are identified as economic beneficiaries of the reported shares?
